Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China
单位：[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.内科学系血液内科华中科技大学同济医学院附属同济医院[2]Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.[3]Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.[4]Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing 100044, China.[5]State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.[6]Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
This work was supported by National High Level Hospital Clinical Research Funding
(BJ-2022-169), the National Key Research and Development Program of China
(2022YFC2502600, 2022YFC2502606, 2021YFA1101503), the National Natural Science
Foundation of China (82170206, 82170208), CAMS Innovation Fund for Medical
Sciences (2019-I2M-5-034, 2022-I2M-C&T-B-121), Peking University People’s Hospital
Research and Development Funds (RZ2022-02) and Shanghai Municipal Health
Commission Project of Disciplines of Excellence (20234Z0002).
第一作者单位：[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
共同第一作者：
通讯作者：
通讯机构：[3]Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.[4]Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing 100044, China.[5]State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.[6]Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
推荐引用方式(GB/T 7714)：
Cao Yang,Zhang Chunli,Zhao Xiaosu,et al.Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China[J].BONE MARROW TRANSPLANTATION.2023,58(12):1413-1415.doi:10.1038/s41409-023-02106-0.
APA：
Cao Yang,Zhang Chunli,Zhao Xiaosu,Huang Jiayu,Zhang Zilu...&Hu Xiaoxia.(2023).Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China.BONE MARROW TRANSPLANTATION,58,(12)
MLA：
Cao Yang,et al."Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China".BONE MARROW TRANSPLANTATION 58..12(2023):1413-1415
